Search clinical trials for: PF-05105679
Total 1302 results
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Pfizer; University of Copenhagen and other collaboratorsTerminatedCOVID-19United States, Denmark
-
Case Comprehensive Cancer CenterCompletedAdvanced Breast Cancer | Recurrent Breast Cancer | Stage 4 Breast CancerUnited States
-
Pierre Fabre MedicamentActive, not recruiting
-
Dana-Farber Cancer InstitutePfizerRecruitingPancreatic Cancer | Solid Tumors | Lung Cancer Squamous Cell | Head & Neck CancerUnited States
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Spain, Canada, Australia, United Kingdom, France
-
PfizerCompleted
-
Grupo de Investigação em Bioquímica e Biologia...Ivoclar Vivadent AGUnknownQuality of Life | Tooth BleachingPortugal
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
PfizerCompletedRheumatoid ArthritisUnited States, Bosnia and Herzegovina, Czechia, Russian Federation, Serbia, Poland, Lithuania, South Africa, Bulgaria, Ukraine
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Advanced Solid Tumor With Evidence of Germline or Somatic BRCAUnited States, Israel, Spain, Canada, United Kingdom
-
Dana-Farber Cancer InstitutePfizer; Astellas Pharma IncCompletedCastration-resistant Prostate CancerUnited States
-
PfizerCompletedRheumatoid ArthritisSpain, Korea, Republic of, United States, Poland, Japan, Taiwan, Hungary, Serbia, Germany, Australia, Czechia, Estonia, Bulgaria, New Zealand, Lithuania, Georgia, Russian Federation, Peru, South Africa, Ukraine, Colombia, Brazil, Me... and more
-
National Cancer Institute (NCI)Active, not recruitingMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedOphthalmic SolutionsUnited States
-
PfizerTerminatedType 2 Diabetic NephropathyUnited States
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
Sage TherapeuticsCompletedSevere Postpartum DepressionUnited States
-
PfizerCompletedRheumatoid ArthritisUnited States, Korea, Republic of, Spain, Taiwan, Serbia, Georgia, Australia, Hungary, Czechia, Poland, Mexico, Russian Federation, Bosnia and Herzegovina, Germany, Bulgaria, Croatia, Romania, Slovakia, Ukraine
-
PfizerCompleted
-
Suzhou Kintor Pharmaceutical Inc,Active, not recruitingHCC | Hepatocellular CarcinomaUnited States
-
M.D. Anderson Cancer CenterPfizerCompleted
-
St. Jude Children's Research HospitalCompletedDiffuse Intrinsic Pontine Glioma | High-grade GliomaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
William Beaumont HospitalsCompletedBlood Loss, Surgical | Intraoperative Complications | Complications; Arthroplasty | Shoulder Joint DiseaseUnited States
-
PfizerTerminated
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
Chuangzhen ChenCompleted
-
PfizerCompletedDermatomyositisUnited States, Spain, Hungary, Poland
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerTerminatedCarcinoma, Non-Small Cell LungUnited States, Germany, Italy
-
PfizerCompletedHealthy | Drug InteractionBelgium
-
Visus TherapeuticsRecruiting
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungCanada, Spain, United States, China, Korea, Republic of, United Kingdom, France, Czechia, Japan, Singapore, Taiwan, Australia, Netherlands, India, Turkey, Hong Kong, Argentina, Belgium, Germany, Italy, Mexico, Poland, Russian Federation
-
Institut de Recherche en Sciences de la Sante,...European and Developing Countries Clinical Trials Partnership (EDCTP)CompletedPlasmodium Falciparum Malaria | Malaria DiagnosisBurkina Faso
-
PfizerWithdrawn
-
PfizerCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Malignant Melanoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Australia, Japan, France, Italy
-
Mike O'Callaghan Military HospitalTerminatedDiabetesUnited States
-
PfizerCompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, United Kingdom, Greece, Slovakia, France, Belgium, Ireland, Japan, Spain, China, Sweden, India, Hungary, Switzerland, Russian Federation, Germany, Mexico, Denmark, Austria, Finland, Poland, South Africa
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
University of OxfordPfizer; Belfast Health and Social Care Trust; Queen's University, Belfast; Saint... and other collaboratorsCompletedColorectal Cancer | Solid TumorUnited Kingdom
-
Assiut UniversityCompleted
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditionsUnited States
-
PfizerArvinas Estrogen Receptor, Inc.Completed